MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/2047-1440-2-1

Медицинская библиотека · Transplantation research · 2013

A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients.

Cole Edward H, Prasad G V Ramesh, Cardella Carl J, Kim Joseph S, Tinckam Kathryn J, Cattran Daniel C, Schiff Jeffrey R, Landsberg David N, Zaltzman Jeffrey S, Gill John S

СтатьяПеревод в очереди

Аннотация

BACKGROUND

New onset diabetes mellitus (NODM) and acute rejection (AR) are important causes of morbidity and risk factors for allograft failure after kidney transplantation.

METHODS

In this multi-center, open label, single-arm pilot study, 49 adult (≥18 years of age), low immunologic risk, non-diabetic recipients of a first deceased or living donor kidney transplant received early steroid reduction to 5 mg/day combined with Thymoglobulin® (Genzyme Transplant, Cambridge, MA, USA) induction, low dose cyclosporine (2-hour post-dose (C2) target of 600 to 800 ng/ml) and mycophenolic acid (MPA) therapy.

RESULTS

Six months after transplantation, two patients (4%) developed NODM and one patient (2%) developed AR. Four patients had impaired fasting glucose tolerance based on 75-g oral glucose tolerance testing (OGTT). There was one patient death. There were no episodes of cytomegalovirus (CMV) infection or BK virus nephritis. In contrast, in a historical cohort of n = 27 patients treated with Thymoglobulin induction, and conventional doses of cyclosporine and corticosteroids, the incidence of NODM and AR was 18% and 15%.

CONCLUSIONS

The pilot study results suggest that Thymoglobulin induction combined with early steroid reduction, reduced cyclosporine exposure and MPA, may reduce the incidence of both NODM and AR in low immunological risk patients. A future controlled study enriched for patients at high risk for NODM is under consideration.

TRIAL REGISTRATION: ClinicalTrials.gov: http://NCT00706680.

Для цитирования: Cole Edward H, Prasad G V Ramesh, Cardella Carl J, Kim Joseph S, Tinckam Kathryn J, Cattran Daniel C, Schiff Jeffrey R, Landsberg David N, Zaltzman Jeffrey S, Gill John S. A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients.. Transplantation research. 2013. DOI: 10.1186/2047-1440-2-1.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.